Biopharmaceuticals

In the Section for Biopharmaceuticals we investigate peptides, proteins, and natural products and analogues thereof with high relevance for infectious disease, neurological disease, epigenetic targets, metabolism, cancer, and other life threatening conditions.
We develop and optimize probes for investigation of disease-relevant mechanisms in vitro and in vivo, by applying cutting-edge technologies to glean atomic-scale insight into ligand–protein interactions.